NU-RISE

Portfolio company short bio
NU-RISE is driving the next-generation of radiotherapy by providing real-time patient dose tracking for precise, autonomous and safer radiation oncology.
Portfolio Company Info

Using multiple low-cost and disposable probes, NU-RISE monitors the level of radiation being delivered near the tumor and surrounding organs at risk. Combining this valuable data with NU-RISE’s advanced software, it’s possible to perform treatment adjustments every time a deviation occurs. The ability to track the radiation provides the data that doctors need to target the cancer and while protecting patients from unnecessary radiation and avoiding severe side effects. Doctors can deliver personalized, faster and safer treatments to the 11 Million of patients that need radiotherapy every year.

Card info


Founder/CEO name: Luis Moutinho (LinkedIn)

Founded: 2015
Location: Ilhavo, Portugal
Sector: Health - deep tech; Radiotherapy
Total amount raised (mln EUR): 0.90
Employees range: 2-10

Request a contact